Table 4 Details of the enrolled patients without gastrointestinal symptoms of long COVID-19 at the 3-month follow-up

Male, n (%)

4(50)

Female, n (%)

4(50)

Age, year (min–max)

43.8(28–57)

Hypertension, n (%)

1(12.5)

Diabetes mellitus, n (%)

1(12.5)

Hyperlipidemia, n (%)

1(12.5)

Duration of hospitalization (days)

11.4(6–15)

Symptoms at admission, n (%)

 Fever

7(87.5)

 Diarrhea

2(25)

 Taste disorder

4(50)

Respiratory symptoms, n (%)

 Cough

4(50)

 Rhinorrhea (runny nose)

6(75)

 Other long COVID symptoms (without gastrointestinal symptoms), n (%)

6(75)

 Insomnia

2(25)

 Fatigue

4(75)